Please login to the form below
European biotech
This page shows the latest European biotech news and features for those working in and with pharma, biotech and healthcare.
Investments show UK biotech still booming despite Brexit
UK raised a quarter of all European biotech funds. New figures show the UK life science sector is still in good health, with a strong start to fundraising in early 2019, ... This reflects a continuing shift away from biotech IPOs on European markets,
Latest news
-
Novartis and Syncona back new Swiss biotech Anaveon
Based in Basel, the centre of Switzerland's pharma and biotech cluster, the company has just raised CHF 35m ($34.9m) in a series A financing round.
-
Ex-Pharmacyclics CEO invests $25m in Summit
After Duchenne drug failure, UK biotech looks to new anti-infective. US biotech billionaire Bob Duggan is to invest $25m into antibiotics developer Summit Therapeutics, taking a near-49% stake in ... Bob Duggan. Duggan was chief executive and president
-
Encouraging data for GenSight’s blinding retinal disease gene therapy
Luxturna, was the first ever gene therapy to be approved for any form of genetic blindness in the US, and now it’s edging closer to that all important European approval. ... UK biotech startup Nightstar is also making waves in this space, bagging a fast
-
New leader at Medivir after setbacks
Christine Lind departs Swedish biotech. Shares in Swedish biotech Medivir were sliding this morning on the sudden departure of chief executive Christine Lind, to be replaced by board member Uli Hacksell. ... Hacksell – who is described in a statement
-
Orchard plans IPO as gene therapy pipeline advances
UK biotech seeks funds for expanded rare disease portfolio. UK gene therapy specialist Orchard Therapeutics has filed registration documents for an initial public offering, just weeks after its latest $150m private ... Add in capital projects such as a
More from news
Approximately 11 fully matching, plus 31 partially matching documents found.
Latest Intelligence
-
European venture funding for the life science sector
Capital markets infrastructure is a barrier. European biotech companies continue to find it hard to raise public money in Europe. ... Pockets of success on Euronext mask the fact that leading European venture groups primarily look to the Nasdaq, at least
-
European sites
very large European life science industry offers a fertile ground for investments, collaboration and acquisitions. ... Key findings. In total there are roughly 11, 000 life science companies (biotech, pharma, medtech) across 14 European countries and in
-
Pharma deals in March 2015
One of Bavarian Nordic's sites is in Martinsried, the biotech cluster near Munich. ... The Morphosys story highlights the uncertainty of funding for European biotech companies.
-
Pharma deals during December 2012
Another deal involving European biotech companies is the acquisition of the Austrian company Intercell by Vivalis based in France for an all share deal valued at $174m. ... Both companies are loss making. It is billed as “a merger of equals”, with
-
Interview with Andrea Rappagliosi, EuropaBio
The current financial crisis exacerbates the task. I think that in the wider context of the pharmaceutical industry, the European biotech industry can definitely play a role in boosting investment in ... From a biotech perspective, the proposed single
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Paris biocluster appoints Stéphane Roques as new chief
Former general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment
-
Apeiron bolsters management board
With more than 25 years’ experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently ... He said: “Apeiron is
-
Novimmune expands senior management team
He is currently a board member of German biotech Epiontis, and has previously served as chief financial officer of PregLem and chairman of Aimago. ... Prior to this, Dr Zimmerman was a European biotech analyst at UBS Investment Bank.
-
MRC Technology appoints director of technology transfer
Farquharson is additionally appointed to the EU Commission's Expert Group, advising on the European Biotech Directive's impact on patent law and R&D activities.
-
Creabilis names Catherine Moukheibir as chairman of the board
After an initial career in strategy consulting and investment banking, she held a number of senior management role at European biotech firms including CFO at Movetis, non-executive board member at
More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.
Featured jobs
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Account Manager, Medical Communications, London
-
Excellent package
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Scientific Director – Medical Communications
-
Salary TBC
-
Health Consultant - Brand Comms
-
Competitive Salary
Subscribe to our email news alerts
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- 50 questions for delivering an exceptional healthcare brand experience
- Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
- The brand strategy revolution
- Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
